Link: http://www.fda.gov/AboutFDA/CentersOffices/NCTR/WhatWeDo/NCTRPublications/ucm076767.htm
"Current Highlight from May 6, 2011
Human Microbiome Conference—April 27-28, 2011
Carl Cerniglia, Ph.D., Director, Division of Microbiology, served as a panel member at the National Academy of Sciences Environmental Health Decisions workshop, “Interplay of the Microbiome, Environmental Stressors and Human Health,” to discuss the impact of widespread antimicrobial use on susceptibility, global health, and drug toxicity. The goal of the workshop was to facilitate discussions among government, industry, academia, and environmental groups concerning scientific advances and emerging knowledge on the microbiome and its relationship to human health.
Antimicrobial Resistance in Salmonella enterica serovar Dublin
NCTR scientists and collaborators from Sam Houston State University and the Marshfield Clinic Research Foundation have identified plasmids containing both antimicrobial-resistance genes and virulence genes from isolates of multidrug-resistant strains of Salmonella enterica serovar Dublin (S. Dublin). Human infections by S. Dublin often result in severe invasive infections typically requiring hospitalization and antimicrobial therapy. Furthermore, bacterial plasmids provide a mechanism for transfer of these genes to other bacteria. (Food Research International, In Press). Preprints are available from Steve Foley, Ph.D., Division of Microbiology, NCTR."
Â
- Minuteman
- Trader Feedback: 0
-
- offline
- 113 Posts. Joined 2/2011
- Location: Australia
- Select All Posts By This User
